Singapore’s pharmaceutical exports are worth about S$4 billion (US$3.1 billion), making up 13 per cent of its domestic exports to the US.
Beijing's efforts to rein in aggressive pricing strategies are showing some results, reflected in smaller declines in factory-gate prices.
